Evidence map›Paper›PMID 29578542›Full record

ArticleAdvanced materials technologies2017

A Tailorable In-Situ Light-Activated Biodegradable Vascular Scaffold.

Mazen S Albaghdadi, Jian Yang, Jessica H Brown, Neel A Mansukhani, Guillermo A Ameer, Melina R Kibbe

Abstract read
In one paragraph

Article in Advanced materials technologies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mazen S AlbaghdadiDepartment of Medicine, Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Jian YangBiomedical Engineering Department, Northwestern University, Evanston, Illinois.
Jessica H BrownSimpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago Illinois.
Neel A MansukhaniSimpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago Illinois.
Guillermo A AmeerSimpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago Illinois.
Melina R KibbeSimpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago Illinois.

Funding

Vascular Surgery Scientist Training ProgramT32HL094293 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ESKANDARI, MARK K · 2009 to 2023
$4.0M
A Revolutionary Therapy for Atherosclerosis: Liquid Cast Arterial StentsRC1HL100491 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI AMEER, GUILLERMO ANTONIO · 2009 to 2010
$994k
Evaluation of the Efficacy of a Liquid Cast Drug-Eluting Biodegradable StentF32HL118976 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ALBAGHDADI, MAZEN · 2013 to 2014
$115k
NHLBI NIH HHS F32 HL118976NHLBI NIH HHS RC1 HL100491NHLBI NIH HHS T32 HL094293
6 · The paper itself

Abstract

Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease that have been developed to overcome the limitations of traditional metallic drug-eluting stents (DES). The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, we describe the engineering of an

Identifiers

PMID29578542
PMCPMC5860681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.